The World Trade Organization has for months faced calls to temporarily remove patent protections on coronavirus vaccines, in a bid to get the drugs to poorer countries struggling to inoculate their people.
The US has backed the proposal, but some European leaders have expressed scepticism over whether a waiver will improve accessibility.
"China supports the World Trade Organization's proposal on intellectual property exemptions, for anti-epidemic materials such as Covid-19 vaccines, to enter the text consultation stage," Chinese commerce ministry spokesman Gao Feng said.
Beijing believes the WTO can play an "active role" in improving vaccine availability globally, he said, though he did not elaborate on further moves by the world's second-largest economy.
Shares in Asia-listed vaccine makers tumbled last week after the US backed the plan for a waiver on Covid-19 patent protections -- including those of Chinese companies like Shanghai Fosun Pharmaceutical and CanSino Biologics.
Fosun has rights to develop and market BioNTech's shot in China, while CanSino manufactures one of the country's primary domestic vaccines.
| The content herein, unless otherwise known to be public domain, is Copyright 1995-2026 Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principles for news reporting and research purposes. |
